Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI
Alessandro Spirito,Dipti Itchhaporia,Samantha Sartori,Edoardo Camenzind,Alaide Chieffo,George D Dangas,Soren Galatius,Raban V Jeger,David E Kandzari,Adnan Kastrati,Hyo-Soo Kim,Takeshi Kimura,Martin B Leon,Laxmi S Mehta,Ghada W Mikhail,Marie-Claude Morice,Johny Nicolas,Brunna Pileggi,Patrick W Serruys,Pieter C Smits,P Gabriel Steg,Gregg W Stone,Marco Valgimigli,Birgit Vogel,Clemens von Birgelen,Giora Weisz,William Wijns,Stephan Windecker,Roxana Mehran
DOI: https://doi.org/10.4244/EIJ-D-23-00086
2023-08-21
EuroIntervention
Abstract:Background: For women undergoing drug-eluting stent (DES) implantation, the individual and combined impact of chronic kidney disease (CKD) and diabetes mellitus (DM) on outcomes is uncertain. Aims: We sought to assess the impact of CKD and DM on prognosis in women after DES implantation. Methods: We pooled patient-level data on women from 26 randomised controlled trials comparing stent types. Women receiving DES were stratified into 4 groups based on CKD (defined as creatine clearance <60 mL/min) and DM status. The primary outcome at 3 years after percutaneous coronary intervention was the composite of all-cause death or myocardial infarction (MI); secondary outcomes included cardiac death, stent thrombosis and target lesion revascularisation. Results: Among 4,269 women, 1,822 (42.7%) had no CKD/DM, 978 (22.9%) had CKD alone, 981 (23.0%) had DM alone, and 488 (11.4%) had both conditions. The risk of all-cause death or MI was not increased in women with CKD alone (adjusted hazard ratio [adj. HR] 1.19, 95% confidence interval [CI]: 0.88-1.61) nor DM alone (adj. HR 1.27, 95% CI: 0.94-1.70), but was significantly higher in women with both conditions (adj. HR 2.64, 95% CI: 1.95-3.56; interaction p-value <0.001). CKD and DM in combination were associated with an increased risk of all secondary outcomes, whereas alone, each condition was only associated with all-cause death and cardiac death. Conclusions: Among women receiving DES, the combined presence of CKD and DM was associated with a higher risk of the composite of death or MI and of any secondary outcome, whereas alone, each condition was associated with an increase in all-cause and cardiac death.